New study finds GLP-1 receptor agonists associated with lower risk of alcohol-related hospitalization among adults with alcohol use disorder

A multi-system study analyzing electronic health records from over 40,000 adults with alcohol use disorder found that GLP-1 receptor agonists (semaglutide and tirzepatide) were associated with 22-26% lower risk of alcohol-related hospitalization in patients with type 2 diabetes, and 32% lower risk in patients with obesity, compared to alternative treatments. Researchers emphasize the need for randomized clinical trials to establish causation.